Recent data indicated that microglial repopulation following experimental depletion using pharmacological colony-stimulating factor 1 receptor (CSF1R) inhibition could effectively resolve inflammation and promote disease recovery after brain injury, without any apparent adverse effects [33]. Here, CSF1R is linked to injury.